Discover trends, market shifts, and competitive outlooks for the automated compounding devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Milestones in the Automated Compounding Devices Market’s Growth Trajectory From 2025 To 2034?

There has been a considerable growth in the size of the automated compounding devices market in the recent past. The market, which was worth $2.36 billion in 2024, is projected to increase to $2.53 billion in 2025, recording a compound annual growth rate (CAGR) of 7.4%. Factors contributing to this growth during the historic period include the increase in chronic disease incidences, an aging demographic, enhancements in healthcare infrastructure, regulatory stipulations, and the rise in medication mistakes.

The market for automated compounding devices is predicted to experience a substantial growth in the coming years, increasing to $3.34 billion by 2029 with a 7.2% compound annual growth rate (CAGR). This predicted growth in the forecast period can be credited to the escalating incidence of cancer, the worldwide healthcare growth, a greater emphasis on patient security, regulatory approval, and a heightened focus on sustainability. Key trends for the forecast period encompass telemedicine, remote healthcare, artificial intelligence development, digitization in healthcare, and real-time monitoring.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18231&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Automated Compounding Devices Market?

The rise in the number of tailored medical treatments is anticipated to propel the growth of the automated compounding devices market. Personalized medicine is a medical strategy that customizes healthcare decisions, practices, procedures, and interventions based on each patient’s specific characteristics. The advancement in the number of individualized medicines is attributed to improved comprehension of genetics, patient-centric data, and regulatory backing. Automated compounding devices are vital instruments that ensure accurate and exact composition of tailor-made medication prescriptions suited to every individual’s needs. These appliances streamline the process of merging various pharmaceutical constituents in precise proportions, a necessary aspect of developing personalized therapies. To illustrate, the Personalized Medicine Coalition, a US-based non-profit organization, pointed out in February 2024 that the FDA approved sixteen new personalized treatments for rare disease patients in 2023 versus just six in 2022. Hence, the surge in the number of tailor-made medicines is assisting in driving the automated compounding devices market’s expansion.

Which Segments in the Automated Compounding Devices Offer the Most Growth?

The automated compounding devices market covered in this report is segmented –

1) By Component: Automated Compounding Systems Equipment, Automated Compounding Systems Software

2) By Product Type: Intravenous Compounding Systems, Oral Compounding Systems, Total Parenteral Nutrition (TPN) Compounding Systems

3) By Mode Of Operation: Fully Automated Compounding Systems, Semi-Automated Compounding Systems

4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Automated Compounding Systems Equipment: Compounding Workstations, Compounding Pumps, Mixing Chambers, Scales And Balances, Dispensing Units, Vial And Syringe Filling Systems, Other Related Equipment (Filtration Devices)

2) By Automated Compounding Systems Software: Prescription Management Software, Workflow Management Software, Monitoring And Control Software, Data Analytics And Reporting Software, Safety And Compliance Software, Integration Software For Hospital Or Pharmacy Management Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=18231&type=smp

What Are the Fastest-Growing Geographies in the Automated Compounding Devices Market?

North America was the largest region in the automated compounding devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated compounding devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in the Automated Compounding Devices Market Over the Coming Years?

Leading firms in the automated compounding device sector are striving to decrease medication errors and boost patient safety via cutting-edge technologies like robotic compounding, with an eye to increasing client confidence, achieving regulatory compliance, and securing an edge in the competition. Robotic compounding technology automates the careful preparation and blending of pharmaceutical compounds using sophisticated robotic systems, thereby improving precision, efficiency, and safety in the preparation of medications. To provide an example, in March 2022, Omnicell Inc., a healthcare technology firm based in the United States, introduced the IVX Station, a novel automated compounding device. With this innovative solution, the company hopes to widen the availability of IV robotic technology in the larger market, promoting patient safety, precision, cost-effectiveness, supply chain management, and regulatory conformity. The IVX Station has a throughput speed three times faster than existing IV robotic systems, features a robust design to reduce downtime, and retains a compact size perfect for pharmacy operations.

View the full report here:

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

What Are the Key Elements That Define the Automated Compounding Devices Market?

Automated compounding devices refer to specialized equipment designed to automate the preparation of medications, including intravenous (IV) solutions, in healthcare settings. These devices ensure precise and efficient compounding, enhancing patient safety and reducing the risk of human error in medication preparation.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18231

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.